|
2015 Conference Publication Sub inhibitory erythromycin reduces the expression of key P. aeruginosa virulence determinants in non-CF bronchiectasis subjectsBurr, L., Rogers, G., Taylor, S., McGuckin, M. and Serisier, D. (2015). Sub inhibitory erythromycin reduces the expression of key P. aeruginosa virulence determinants in non-CF bronchiectasis subjects. Thoracic Society Australia New Zealand Australian New Zealand Society Respiratory Science Annual Scientific Meeting 2015, Queensland Australia, Mar 27-Apr 01, 2015. Hoboken, NJ United States: Wiley-Blackwell. |
|
2015 Conference Publication Collagen protease levels vary with airway microbiota composition and lung function in bronchiectasisTaylor, S., Rogers, G., Chen, A., Burr, L., McGuckin, M. and Serisier, D. (2015). Collagen protease levels vary with airway microbiota composition and lung function in bronchiectasis. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science, Annual Scientific Meeting, Gold Coast, Australia, 27 March – 1 April 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12495_14 |
|
2015 Conference Publication Spatial variation in the composition of infective lung microbiota revealed by 16S rRNA gene sequence analysis of multisite bronchoalveolar lavageScoleri, G., Leong, L., Burr, L., Choo, J., Thomson, R., Serisier, D. and Rogers, G. (2015). Spatial variation in the composition of infective lung microbiota revealed by 16S rRNA gene sequence analysis of multisite bronchoalveolar lavage. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science, Annual Scientific Meeting 2015, Gold Coast, Australia, 27 March – 1 April 2015. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12494_8 |
|
2014 Journal Article The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trialRogers, Geraint B., Bruce, Kenneth D., Martin, Megan L., Burr, Lucy D. and Serisier, David J. (2014). The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial. The Lancet Respiratory Medicine, 2 (12), 988-996. doi: 10.1016/S2213-2600(14)70213-9 |
|
2014 Journal Article A novel microbiota stratification system predicts future exacerbations in bronchiectasisRogers, Geraint B., Zain, Nur Masirah M., Bruce, Kenneth D., Burr, Lucy D., Chen, Alice C., Rivett, Damian W., McGuckin, Michael A. and Serisier, David J. (2014). A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Annals of the American Thoracic Society, 11 (4), 496-503. doi: 10.1513/AnnalsATS.201310-335OC |
|
2014 Conference Publication PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR Γ GENE EXPRESSION IN THE AIRWAYS OF NON CYSTIC FIBROSIS BRONCHIECTASIS SUBJECTS IS INVERSELY CORRELATED WITH TOTAL PSEUDOMONAS AERUGINOSA BACTERIAL LOAD BUT POSITIVELY CORRELATED WITH ABSOLUTE MACROPHAGE LEVELSBurr, L., Rogers, G., Chen, A. and Serisier, D. (2014). PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR Γ GENE EXPRESSION IN THE AIRWAYS OF NON CYSTIC FIBROSIS BRONCHIECTASIS SUBJECTS IS INVERSELY CORRELATED WITH TOTAL PSEUDOMONAS AERUGINOSA BACTERIAL LOAD BUT POSITIVELY CORRELATED WITH ABSOLUTE MACROPHAGE LEVELS. HOBOKEN: WILEY-BLACKWELL. |
|
2014 Conference Publication Proportional Antimicrobial Susceptibility Testing of Whole Cystic Fibrosis Sputum-A Pilot StudyVisser, S., Burr, L., Rogers, G. and Serisier, D. (2014). Proportional Antimicrobial Susceptibility Testing of Whole Cystic Fibrosis Sputum-A Pilot Study. Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, 4-9 April 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_10 |
|
2014 Conference Publication Clinical Benefits of Long-Term, Low-Dose Erythromycin in Bronchiectasis Are Not Due to Modulation of Sputum Mucin ContentChen, A., Martin, M., Lourie, R., Burr, L., Hasnain, S., Bowler, S., Mcguckin, M. and Serisier, D. (2014). Clinical Benefits of Long-Term, Low-Dose Erythromycin in Bronchiectasis Are Not Due to Modulation of Sputum Mucin Content. Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, 4-9 April 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_6 |
|
2014 Conference Publication Domination of the Lower Airway Microbiota by Veillonella Species Is Predictive of Frequent Exacerbation in Non-Cystic Fibrosis BronchiectasisRogers, G., Chen, A., Burr, L. and Serisier, D. (2014). Domination of the Lower Airway Microbiota by Veillonella Species Is Predictive of Frequent Exacerbation in Non-Cystic Fibrosis Bronchiectasis. Annual Scientific Meeting of the Thoracic Society of Australia and New Zealand and the Australian and New Zealand Society of Respiratory Science 2014, Adelaide, SA Australia, 4-9 April 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12262_10 |
|
2014 Conference Publication Human Neutrophil Elastase Activity and Matrix Metalloproteinase Activity Are Markers of Disease Severity in Non-Cf BronchiectasisChen, A., Lourie, R., Martin, M., Burr, L., Hasnain, S., Fantino, E., Bowler, S., Mcguckin, M. and Serisier, D. (2014). Human Neutrophil Elastase Activity and Matrix Metalloproteinase Activity Are Markers of Disease Severity in Non-Cf Bronchiectasis. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2014 Annual Scientific Meetings, Adelaide Australia, 4-9 April 2014. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.12263_6 |
|
2014 Journal Article Miscellaneous antibacterial drugsBurr, Lucy, Cunningham, Jordan and Serisier, David (2014). Miscellaneous antibacterial drugs. Side Effects of Drugs Annual, 36, 363-380. doi: 10.1016/B978-0-444-63407-8.00026-5 |
|
2013 Conference Publication Clinical Benefits Of Long-Term, Low-Dose Erythromycin In Bronchiectasis Are Not Due To Anti-Inflammatory EffectsChen, A. C., Martin, M. M., Burr, L., Hasnain, S. Z., Lourie, R., Bowler, S. D., McGuckin, M. A. and Serisier, D. J. (2013). Clinical Benefits Of Long-Term, Low-Dose Erythromycin In Bronchiectasis Are Not Due To Anti-Inflammatory Effects. American Thoracic Society 2013 International Conference, Philadelphia, PA, United States, 17-22 May 2013. New York, United States: American Thoracic Society. |
|
2012 Journal Article An unusual radiological presentation of pulmonary Langerhans' cell histiocytosisBurr, Lucy, Fanning, Steven, Wong, David and Bowler, Simon (2012). An unusual radiological presentation of pulmonary Langerhans' cell histiocytosis. BMJ Case Reports, 2012 (jul02 1), 1-4. doi: 10.1136/bcr-03-2012-5980 |
